Page 63 - Technical Research News Today

Get latest articles and stories on Latest News at LatestLY. Quarterly earnings from IT majors Tata Consultancy Services (TCS), Infosys, macroeconomic data announcements, global trends and trading activity of foreign investors would guide the movement in the equity market this week, analysts said. Latest News | Quarterly Earnings, Macroeconomic Data, Global Trends to Drive Markets This Week: Analysts.

Quarterly earnings from IT majors Tata Consultancy Services (TCS), Infosys, macroeconomic data announcements, global trends and trading activity of foreign investors would guide the movement in the equity market this week, analysts said. Movement of global oil benchmark Brent crude and the rupee will also influence trading in the markets. All eyes will be on the beginning of corporate performance for the second quarter of the current fiscal year. TCS is slated to unveil its Q2 results on October...

TCS to unveil its Q2 results on October 11, HCL Technologies, Infosys on October 12

Given Niftys overarching bullish tilt and its position adjacent to a strategic support zone, there lies a palpable potential of it rallying towards the 20,000 milestone, provided it surpasses the 19,800 resistance

Buy or sell stocks: Vaishali Parekh has recommended three stocks to buy today — McDowell-N or United Spirits, IndiGo and Bombay Dyeing

There weren’t any surprises in the Governors’ statement. Sometimes no news is good news, which is why markets have reacted with a slightly positive bias, says Apurva Sheth, Head of Market Perspectives & Research at SAMCO Securities.

India Business News: Benchmark equity indices Sensex and Nifty rallied for a second straight session on Friday after the Reserve Bank maintained the status quo on policy r

The short-term trend of Nifty has turned positive. The overall positive chart pattern indicates next overhead resistance for the Nifty around 19,800 levels for the coming week. Any dip down to 19,550-19,500 levels could be a buying opportunity, said Nagaraj Shetti of HDFC Securities

Social media is full of misguided claims about lab-grown meat. Amid criticism about nutrition and sustainability, one such claim is that it's made from cancer cells. Spoiler alert: It's not. DW takes a closer look.

Short term traders can look to buy the stock now as the momentum is likely to continue which could take the stock to fresh 52-week highs of 240-280 levels, suggest experts.